ABCG2 and non-small cell lung carcinoma: Collectively, these findings suggest that GH promotes chemoresistance in NSCLC by upregulating ABC transporter expression, while pegvisomant effectively counteracts this effect, highlighting its potential therapeutic role in sensitizing tumors to chemotherapy.